Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up
D. Ponticelli, Fabiana Madotto, Sara Conti, et al.
Internal and Emergency Medicine (2021) Vol. 17, Iss. 2, pp. 481-486
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

The Effect of Smoking on Humoral Response to COVID-19 Vaccines: A Systematic Review of Epidemiological Studies
Pietro Ferrara, Vincenza Gianfredi, Venera Tomaselli, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 303-303
Open Access | Times Cited: 73
Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies
Pietro Ferrara, D. Ponticelli, Fernando Agüero, et al.
Public Health (2022) Vol. 203, pp. 97-99
Open Access | Times Cited: 49
Patients with Liver Cirrhosis Show High Immunogenicity upon COVID-19 Vaccination but Develop Premature Deterioration of Antibody Titers
Katharina Willuweit, Alexandra Frey, Moritz Passenberg, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 377-377
Open Access | Times Cited: 39
Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months
D. Ponticelli, Ippazio Cosimo Antonazzo, Grazia Caci, et al.
Journal of Travel Medicine (2021) Vol. 28, Iss. 8
Open Access | Times Cited: 27
Homologous and Heterologous Anti-COVID-19 Vaccination Does Not Induce New-Onset Formation of Autoantibodies Typically Accompanying Lupus Erythematodes, Rheumatoid Arthritis, Celiac Disease and Antiphospholipid Syndrome
Christoph Thurm, Annegret Reinhold, Katrin Borucki, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 333-333
Open Access | Times Cited: 18
Risk of Repeated Adverse Effects following Booster Dose of mRNA COVID-19 Vaccine: Results from the MOSAICO Study
Pietro Ferrara, D. Ponticelli, Lorenzo Losa, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 247-247
Open Access | Times Cited: 9
The effect of laboratory-verified smoking on SARS-CoV-2 infection: results from the Troina sero-epidemiological survey
Venera Tomaselli, Pietro Ferrara, Giulio Giacomo Cantone, et al.
Internal and Emergency Medicine (2022) Vol. 17, Iss. 6, pp. 1617-1630
Open Access | Times Cited: 13
Time-Varying Effect of Hybrid Immunity on the Risk of Breakthrough Infection after Booster Dose of mRNA COVID-19 Vaccine: The MOSAICO Study
Pietro Ferrara, D. Ponticelli, Roberto Magliuolo, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1353-1353
Open Access | Times Cited: 11
Smoking habits predict adverse effects after mRNA COVID-19 vaccine: Empirical evidence from a pilot study
D. Ponticelli, Lorenzo Losa, Davide Campagna, et al.
Public Health (2023) Vol. 219, pp. 18-21
Open Access | Times Cited: 5
A quick scoping review of the first year of vaccination against the COVID-19 pandemic: Do we need more shots or time?
Ayman El‐Menyar, Naushad Ahmad Khan, Ahammed Mekkodathil, et al.
Medicine (2022) Vol. 101, Iss. 37, pp. e30609-e30609
Open Access | Times Cited: 8
High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium
Bas Calcoen, Nico Callewaert, Aline Vandenbulcke, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1257-1257
Open Access | Times Cited: 7
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply
Pietro Ferrara, Ippazio Cosimo Antonazzo, Riccardo Polosa
Internal and Emergency Medicine (2022) Vol. 17, Iss. 1, pp. 313-314
Open Access | Times Cited: 6
Common adverse events following immunization with the COVID-19 comirnaty vaccine (Pfizer-BioNTech) among adult population in Hanoi, Vietnam, 2021
Xuan Thi Thanh Le, Quan Long Hoang, Nhung Thi Kim Ta, et al.
Frontiers in Tropical Diseases (2022) Vol. 3
Open Access | Times Cited: 6
Progress and prospects for artificial intelligence in clinical practice: learning from COVID-19
Pietro Ferrara, Sebastiano Battiato, Riccardo Polosa
Internal and Emergency Medicine (2022) Vol. 17, Iss. 7, pp. 1855-1857
Open Access | Times Cited: 6
COVID-19 Preventive Practices, Psychological Distress, and Reported Barriers to Healthcare Access during the Pandemic among Adult Community Members in Sub-Saharan Africa: A Phone Survey
Nega Assefa, Yasir Y. Abdullahi, Elena C. Hemler, et al.
American Journal of Tropical Medicine and Hygiene (2022) Vol. 108, Iss. 1, pp. 124-136
Open Access | Times Cited: 6
Measuring meningococcal vaccination coverage among adolescents in Italy: state-of-the-art and regional challenges.
Pietro Ferrara, Luciana Albano, Vincenza Gianfredi
PubMed (2022) Vol. 93, Iss. 3, pp. e2022069-e2022069
Closed Access | Times Cited: 5
COVID-19 mRNA vaccine safety, immunogenicity, and effectiveness in a hospital setting: confronting the challenge
Janet Sultana, Grazia Caci, Giulia Hyeraci, et al.
Internal and Emergency Medicine (2022) Vol. 17, Iss. 2, pp. 325-327
Open Access | Times Cited: 4
The Importance of Real-World Evidence in Understanding Influenza Vaccine Effectiveness
Pietro Ferrara, LG Mantovani
Farmeconomia Health economics and therapeutic pathways (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 4
BNT162b2 COVID-19 Vaccine Safety among Healthcare Workers of a Tertiary Hospital in Italy
Flavia Beccia, Luca Regazzi, Eleonora Marziali, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 477-477
Open Access | Times Cited: 2
Long follow-up of BNT162b2 mRNA vaccine in healthcare workers (2020–2022): A retrospective longitudinal SARS-CoV-2 serological surveillance
Vanessa De Pace, Bianca Bruzzone, Valentina Ricucci, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 1
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up: comment
Cristina Serraino, Remo Melchio, Marco Badinella Martini, et al.
Internal and Emergency Medicine (2022) Vol. 17, Iss. 1, pp. 311-312
Open Access | Times Cited: 1
The temporal correlation between positive testing and death in Italy: from the first phase to the later evolution of the COVID-19 pandemic.
Vincenzo d’Alessandro, Nicole Balasco, Pietro Ferrara, et al.
PubMed (2022) Vol. 92, Iss. 6, pp. e2021395-e2021395
Closed Access | Times Cited: 1
Continued disruptions in health care services and mental health among health care providers during the COVID-19 pandemic in five sub-Saharan African countries
Nega Assefa, Yasir Y. Abdullahi, Elena C. Hemler, et al.
Journal of Global Health (2022) Vol. 12
Open Access | Times Cited: 1
The Impact of Smoking on Anti-COVID-19 Antibody Titers After Vaccination: A Narrative Review in Some Asian Countries
Amirhossein Fakhre Yaseri
Tobacco and Health (2023) Vol. 2, Iss. 1, pp. 33-36
Open Access
Mpox Vaccination in Non-Endemic Countries: Considerations for Public Health and Policy
Pietro Ferrara
Vaccines (2023) Vol. 11, Iss. 9, pp. 1406-1406
Open Access
Page 1 - Next Page

Scroll to top